Podcasts about rochester medical center

Black women in America are three times more likely to die from pregnancy-related causes than white women. It's a crisis fueled by systemic racism, medical bias, and structural inequities. But there's also a growing movement to push back. Community-based doulas are stepping in to support Black mothers throughout pregnancy, birth, and beyond. They're advocating, empowering, and providing care that's culturally rooted and deeply personal. This hour, guest host Racquel Stephen and her guests explore the role of doulas in Black maternal health, how and why they do what they do, and whether they are making a difference. Our guests: Jasmine Brewer, doula program manager at the Healthy Baby Network Ayanah Alexander, doula at the Healthy Baby Network Stefanie Hollenbach, M.D., Ph.D., assistant professor of obstetrics and gynecology and biomedical engineering at the University of Rochester Medical Center

For the past four years, former Democrat and Chronicle journalist Erica Bryant has turned her attention to reporting on the dream world. Bryant has gone deep, interviewing people about their dreams, and collecting hundreds of dream stories. She's preparing to debut her exhibition "Other People's Dreams" at the Rochester Contemporary Art Center. But first, she and some of her dream interviewees join us on "Connections" to explore what our dreams mean: why we have them; what they say about our lives and desires; and what the experts say. Our guests: Erica Bryant, artist and associate director of writing at the Vera Institute of Justice Jon Gary, musician and artist Davida Rogers, graduate student and artist Wilfred Pigeon, Ph.D., professor of psychiatry and public health sciences and director of the Sleep and Neurophysiology Research Lab at the University of Rochester Medical Center

Erika Moseson, MD, of the Air Health Our Heath podcast hosts this week's episode with guest Daniel Croft, MPH, ATSF. Dr. Croft is associate professorin the Department of Environmental Medicine at the University of Rochester Medical Center. On this episode we share insights from the Climate Change and Respiratory Health: Opportunities to Contribute to Environmental Justice: An Official American Thoracic Society Workshop Report - https://pubmed.ncbi.nlm.nih.gov/40311081/For additional discussion on environmental health, please also view our recent Breathe Easy episode 12 “EPA Rollbacks Spell Grave Impacts on Public Health” for an up-to-date discussion of current national changes related to health care, environmental health and environmental justice:  And for ATS members, please review the Washington Letter for up to date actions ATS is taking to protect respiratory health:  https://urldefense.proofpoint.com/v2/url?u=https-3A__site.thoracic.org_about-2Dus_news_washington-2Dletter&d=DwMFAg&c=shNJtf5dKgNcPZ6Yh64b-ALLUrcfR-4CCQkZVKC8w3o&r=cBcAqdnwqc2JZQ0oH6i362XLRsQ-_Tz-M1Wc9UELJNs&m=MdI_1W73157uyTefcBrkHA9wu2ITlxReWhEVndIGRsDlh5tkbX4XmkSOaeWSnB1a&s=yhFeE9pojesBPCkULoIjDdlcHL_vqKUR6d_rwIEVw0Y&e=

Health and Human Services Secretary Robert F Kennedy Jr. recently made a series of remarks about autism. RFK spoke about “severe autism” and said he lamented the difficult lives that people with severe autism have to lead. He even talked about creating a “national autism registry,” although his office later walked back that idea. Meanwhile, researchers — including those within his own agency — are pushing back on a number of claims RFK has made about some of the facts surrounding the condition. This hour, Evan and co-host Sarah Murphy Abbamonte sit down with a local clinician and autism awareness advocates to discuss the facts, their experiences, and the ways that autism has affected them. In studio: Dylan Dailor, autistic self-advocate Jerri Lynn Sparks, autism acceptance, appreciation, awareness, and inclusion advocate for nearly 30 years, and proud mother of a son with autism (and his three siblings) Laura Silverman, Ph.D., associate professor and clinical child psychologist in the Division of Developmental and Behavioral Pediatrics at the University of Rochester Medical Center

Dr. Nimish Mohile and Dr. Jaishri Blakeley share the new rapid recommendation update to the therapy for diffuse astrocytic and oligodendroglial tumors in adults guideline. They review the evidence from the INDIGO trial that prompted this update, and how to incorporate the use of vorasidenib into clinical practice. They discuss the importance of molecular testing, particularly for IDH1 or IDH2 mutations and outstanding questions for treatment of patients with oligodendrogliomas and astrocytomas. Read the latest update, “Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.” Transcript This guideline, clinical tools, and resources are available at http://www.asco.org/neurooncology-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in Journal of Clinical Oncology.   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts.   My name is Brittany Harvey and today I'm interviewing Dr. Jaishri Blakeley from Johns Hopkins University School of Medicine and Dr. Nimish Mohile from the Department of Neurology and Wilmot Cancer Institute at the University of Rochester Medical Center, co-chairs on “Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: American Society of Clinical Oncology-Society for Neuro-Oncology Guideline Rapid Recommendation Update.”  Thank you for being here today, Dr. Blakeley and Dr. Mohile.  Dr. Jaishri Blakeley: Thank you.  Dr. Nimish Mohile: Thank you for having us.  Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Blakeley and Dr. Mohile who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes.   So then, to jump into the content here, Dr. Mohile, could you start us off by describing what prompted this rapid update to the ASCO-SNO therapy for diffuse astrocytic and oligodendroglial tumors in adults guideline, which was previously published in 2021?  Dr. Nimish Mohile: Yeah. So the key reason for this update is the publication of a study in 2023. And this was a study called the INDIGO study that looked at a new class of therapies, something called IDH inhibitors. And in this study with a drug called vorasidenib, changed how we think about the treatment of oligodendrogliomas and astrocytomas, so particularly the grade 2 oligodendrogliomas and grade 2 astrocytomas. Because of the results of that study, we decided that we needed to do an update to inform clinicians about some of these changes and how we might approach these tumors differently today.  Brittany Harvey: Great. I appreciate that background. So then, based off the new data from the INDIGO study, what are the updated and new recommendations from the expert panel?  Dr. Nimish Mohile: So the key findings from the INDIGO study involved people who had grade 2 astrocytomas and grade 2 oligodendrogliomas. And in the setting after surgery, they were treated with vorasidenib, and what they found is that this delayed the time to next intervention. And the key aspect of that is that it delayed when we could start radiation and chemotherapy in these patients.   So what we did in the guidelines is that for both low grade oligodendrogliomas and low grade astrocytomas, we added one additional guideline statement. Our previous guideline in 2021 offered the options for observation or treatment with radiation and chemotherapy. And now in this guideline, we have options for observation, treatment with vorasidenib in those in whom we feel it is safe to defer radiation and chemotherapy, and then treatment with radiation and chemotherapy. So we've added in an additional option here. And the key message of the guideline is really on how, as clinicians, we think about using the vorasidenib and what the ideal setting for using the vorasidenib is.  Brittany Harvey: Excellent. It's great to hear about this new option for patients. So then you were just talking about how we think about who to offer this IDH inhibitor to. So, Dr. Blakeley, what should clinicians know as they implement these new recommendations into practice?  Dr. Jaishri Blakeley: Yes. So, first and foremost, let's go back to 2021, and a key note from those guidelines was the importance of molecular testing. And at that point, the importance of molecular testing, which in large part was focused on IDH1 or IDH2 mutations, was prognostic. We could say there's a difference in an IDH1 mutant astrocytoma and an IDH1 wild type astrocytoma, but we didn't have a specific therapeutic recommendation attached to that, like Dr. Mohile just said. And the big shift here is now we have a specific therapeutic for that population with IDH1 or IDH2 mutant glioma.   So for clinicians, we hope that they've been getting molecular testing on newly diagnosed glioma already, but now there's an additional motivation to do so because it may change your treatment plan in the right circumstance. So since the publication of the phase III INDIGO study that Dr. Mohile mentioned, and the FDA approval of vorasidenib, if you meet the specified criteria in the clinical trial - which the guidelines point out is a little different than what's on the FDA label, so clinicians might want to dig into that a little bit - then there is a treatment option that is new and different than combined chemoradiation or radiation alone or observation.  Brittany Harvey: I appreciate those clarifications there.   So then also, Dr. Blakeley, how does this update impact patients with astrocytic or oligodendroglial tumors?  Dr. Jaishri Blakeley: So first, patients also should know if they have IDH mutant gliomas. And this update only applies to people with IDH1/2 mutant glioma. Perhaps, we're not sure, it might only apply to people who are in the newly or newly-ish diagnosed category because the INDIGO study required that people were within the first five years of their surgical diagnosis and had not had other treatment. So there are a lot of people who have astrocytoma or oligodendroglioma who may or may not know their IDH1/2 status and may have already had another therapy - this update doesn't apply to them. We hope that future research will teach us about that. This update is for people who are newly diagnosed and just starting the journey to figure out the best therapy. It does say that if you do have that IDH1/2 alteration in your tumor, there is a drug therapy that is different from the drug therapies we would offer gliomas that do not have the IDH1/2 mutation.  Brittany Harvey: Absolutely. I think both that emphasis on molecular testing is very important and also thinking about that study inclusion criteria and how it impacts who's eligible for this treatment.   So then finally, Dr. Mohile, what are the outstanding questions about vorasidenib or other interventions for gliomas in adults?  Dr. Nimish Mohile: I think the key question for clinicians is exactly who we're going to use this in. The challenges with inclusion criteria in clinical trials is they don't actually always match what we're seeing in the clinic. And I think it brings up the question of, in low grade oligodendrogliomas which we think of as very slow growing tumors, do we have the option outside of the strict inclusion criteria to use that drug in other settings? I think it brings up the question for some clinicians in some of the higher grade tumors, in the grade 3 tumors, we don't yet have data in that area and our guideline doesn't address that. But I think some will be asking what the clinical activity of vorasidenib is in that setting. There are some suggestions that the IDH inhibitors may impact seizure control, and I think that that's data that we're continuing to wait on.   So I think that there's several outstanding questions there that we will have answers for hopefully in the next several years. I think the big question that we don't have an answer for and that will take a long time to know is whether the addition of vorasidenib in this setting actually improves how long people live. And given how long people with low grade oligodendrogliomas and low grade astrocytomas live today, we probably won't have an answer to that question for more than a decade.  Brittany Harvey: Definitely. We'll look forward to these ongoing developments and eventually longer term data on overall survival on these agents.   So, I want to thank you both so much for your work to rapidly include this information from this new trial. And thank you for your time today, Dr. Blakeley and Dr. Mohile.  Dr. Jaishri Blakeley: Thank you so much.  Dr. Nimish Mohile: Thank you Brittany.  Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/neurooncology-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.    The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. 

The measles outbreak in the southern United States has caused multiple deaths, marking the first measles fatalities in this country in years. Health and Human Services Secretary Robert F. Kennedy Jr. has sent mixed messages on vaccination and preventive care. In addition, Kennedy has been wrong about how vaccines are tested in children. We talk to local doctors about the best way to care for kids and keep them safe. Our guests: Elizabeth Murray, D.O., associate professor of clinical emergency medicine at the University of Rochester Medical Center, and director of child health and safety communications for Golisano Children's Hospital Justin Rosati, M.D., assistant professor of neurology at the University of Rochester Medical Center

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Handheld ultrasound technology is revolutionizing healthcare by improving bedside diagnosis and enhancing patient outcomes through seamless electronic health record integration. In this episode, Dr. John Martin, Chief Medical Officer of Butterfly Network, and Dr. Mike Rotondo, CEO of the University of Rochester Medical Faculty Group. Dr. Martin discusses Butterfly Network's handheld ultrasound technology, revolutionizing point-of-care testing, while Dr. Rotondo highlights their partnership's success in deploying this device within the University of Rochester's health system. They emphasize how this technology improves bedside diagnosis, shortens the time to treatment, and integrates seamlessly into electronic health records, enhancing workflow and patient outcomes. The conversation focuses on overcoming challenges in adopting new healthcare technologies and the importance of collaborations between academic institutions and innovative tech companies. Tune in to gain valuable insights into how these innovations are shaping the future of healthcare. Resources: Connect with and follow Dr. Michael Rotondo on LinkedIn. Follow the University of Rochester Medical Center on LinkedIn and visit their website. Connect with and follow Dr. John Martin on LinkedIn. Follow Butterfly Network, Inc. on LinkedIn and visit their website. Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Stillbirth affects thousands of families each year, yet misinformation persists. What are the risk factors, and how do disparities in care contribute? Heather Florescue, MD, FACOG, OBGYN at the University of Rochester Medical Center, sheds light on the psychological toll of stillbirth, the often-overlooked postpartum period, and steps to reduce risk during pregnancy and conception. We then spoke to Samantha Banerjee, Executive Director of PUSH for Empowered Pregnancy, shares her personal journey and the advocacy efforts supporting families and driving change. Join us as we explore how to navigate pregnancy concerns, advocate for better care, and break the silence surrounding stillbirth.  See omnystudio.com/listener for privacy information.

Michael Hasselberg, PhD, Chief Digital Health Officer at the University of Rochester Medical Center, discusses the evolving landscape of artificial intelligence governance in healthcare. He highlights growth opportunities in generative AI while addressing regulatory challenges and the complexities of building trust in AI-driven solutions.

Michael Hasselberg, PhD, Chief Digital Health Officer at the University of Rochester Medical Center, discusses the evolving landscape of artificial intelligence governance in healthcare. He highlights growth opportunities in generative AI while addressing regulatory challenges and the complexities of building trust in AI-driven solutions.

On this dual-guest episode of The Digital Patient, Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, and colleague, Alan Sardana, chat with Dr. Michael Hasselberg, Chief Digital Health Officer at University of Rochester Medical Center, and Michael Mainiero, Chief Digital and Chief Information Officer at Catholic Health, about "Why Most AI Pitches Fail, Startup Red Flags, the One Word That Will Get You Blacklisted from Health Systems, and more..."

Alvin and German conduct a great conversation with Obstetrician and Gynecologist at Salinas Valley Health Medical Center, Dr. Kenneth A. Jones, '82. He is dedicated to helping women understand their best options and make informed decisions. Throughout all stages of life, from birth onwards, he provides prevention education, diagnosis, and treatment to improve and sustain women's quality of life. Upon graduation, he earned his medical degree from the University of Rochester School of Medicine and Dentistry in 1989 and completed his residency at the University of Rochester Medical Center. He is board certified by the American Board of Obstetrics and Gynecology. In addition to his medical expertise, Dr. Jones is a wine connoisseur who enjoys reading, traveling, and spending time with friends. He is also known for his great sense of humor and love for a good joke. HE graduated from Colgate with a Bachelor's degree in Biology,

In this podcast episode, Melissa Venable, NCDA's Director of Professional Development, hosts a conversation on creating neurodiverse-affirming practices with Janine Rowe, a licensed mental health counselor, and Elle O'Flaherty, Principal of Interlace Solutions Coaching. They discuss the concept of neurodiversity, which includes conditions like autism and ADHD, and emphasize moving from a deficit to a strengths-based model. They share personal insights and experiences, highlight the importance of understanding individual needs, and offer practical advice for career development professionals working with neurodiverse clients. Key topics include understanding communication differences, the importance of interest-based strengths for ADHD clients, and navigating the complexities of the disclosure process under the Americans with Disabilities Act. The conversation underscores the need for flexible, collaborative approaches to support neurodiverse individuals in career development.Janine Rowe is a doctoral student in Counselor Education at the University of Rochester, in Rochester, NY. She is a licensed mental health counselor, a certified career counselor, and nationally certified counselor in private practice in Rochester, NY. She is currently a counselor at the University of Rochester Medical Center. She was most recently a career counselor and Assistant Director of Disability & Career Services at Rochester Institute of Technology (RIT). She is the winner of the New York State Career Development Association (NYSCDA) Early Career Professional award (2014) and the RIT Presidential Award for Excellence (2018). Janine was a participant in National Career Development Association's Counselor Education and Leadership Academies and is the previous Vice-President and President of the NYSCDA. Elle O'Flaherty, JD, PCC, is a keynote speaker, executive coach, and founder of Interlace Solutions Coaching. Specializing in performance optimization and ADHD strategies, she empowers professionals and organizations to excel. She has been featured in national media outlets including Medium, Yahoo Finance, and Atlassian. Elle delivers research-backed insights and practical tools with humor to enhance productivity, leadership, and career growth. In her previous life, Elle was a litigator and international trade negotiator for nearly 17 years.ResourcesPerson-first languageADA and DisclosureInvestigating Markers of Rapport in Autistic and Nonautistic Interactions - Autism in AdulthoodWant to learn more? Career Planning Academy:Certified Autism Career and Employment Specialist - Instructor: Janine RoweCertified ADHD Career Strategist - Instructor: Elle O'FlahertySend us a text

The U.S. winter virus season is in full force and, by one measure, is the most intense in 15 years. One indicator of flu activity is the percentage of doctor's office visits driven by flu-like symptoms. That number was clearly higher than the peak of any winter flu season since 2009-2010, when a swine flu pandemic hit the nation, according to data posted by the Centers for Disease Control and Prevention (CDC). Of course, other viral infections can be mistaken for flu. But COVID-19 appears to be on the decline, according to hospital data and CDC modeling projections. Available data also suggest another respiratory illness, RSV, has been fading nationally. The flu has forced schools to shut down in some states. The Godley Independent School District, a 3,200-student system near Fort Worth, Texas, was closed for three days after 650 students and 60 staff were out. Jeff Meador, a district spokesman, said the vast majority of illnesses there have been flu, plus some strep throat. He called it the worst flu season he could remember. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths—including at least 57 children. Traditionally, flu season peaks around February. Overall, 43 states reported high or very high flu activity. Flu was most intense in the South, Southwest and Western states. In Rochester, New York, the flu season has been intense but not necessarily worse than at the peak of other years, said Dr. Elizabeth Murray, a pediatric emergency medicine doctor at the University of Rochester Medical Center. U.S. health officials recommend that everyone six months and older get an annual flu vaccination. To avoid seasonal viruses, doctors say you should avoid touching your eyes, nose and mouth because germs can spread that way. You should also wash your hands with soap and water, clean frequently touched surfaces and avoid close contact with people who are sick. This article was provided by The Associated Press.

In this captivating episode of Taking Healthcare by Storm, delve into the world of expert insights as Quality Insights Medical Director Dr. Jean Storm engages in a thought-provoking and informative discussion with Ghinwa Dumyati, MD, Director of the Communicable Diseases Surveillance and Prevention Program at the University of Rochester Medical Center.Dr. Dumyati discusses infectious disease management in long-term care facilities, focusing on COVID-19, vaccination, infection control, antimicrobial stewardship, and combating multi-drug resistant organisms like Candida auris. She highlights the importance of collaboration between healthcare facilities and public health to address current and emerging threats. If you have any topics or guests you'd like to see on future episodes, reach out to us on our website. This material was prepared by Quality Insights, a Quality Innovation Network-Quality Improvement Organization under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. Publication number 12SOW-QI-ARPA-030725-GK

In this powerful episode of Game Over: c*ncer, hosts Val Solomon and Dana Nichols dive into the importance of incorporating patient experience into research.Meet Dr. Annalynn Williams, an assistant professor of surgery and cancer control at the University of Rochester Medical Center, and young adult cancer survivor. Dr. Williams shares how her personal battle with cancer shaped her career path and fueled her passion for survivorship research. She introduces the concept of the survivor scientist and explains how her work focuses on cancer-related cognitive effects and accelerated aging in pediatric, adolescent, and young adult cancer survivors.This episode unpacks the evolving landscape of survivorship research, the critical need to improve post-treatment quality of life, and how research informs safer, more effective treatment options for future generations. Dr. Williams also shares invaluable resources for survivors and caregivers, shedding light on the ongoing work to help patients not just survive—but thrive.Tune in to hear this inspiring and informative conversation. Don't forget to subscribe, leave a review, and join the fight to make Game Over: c*ncer a reality.Learn more about Cannonball Kids' cancer Foundation at www.cannonballkidscancer.org. Like, share, and subscribe to stay informed and inspired! Together, we can make a difference.Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon-516b50b8/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/

In this episode, James Forrester, Chief Technology Officer at University of Rochester Medical Center, shares highlights from the organization's recent initiatives, including groundbreaking ambient scribe technology and a robust data strategy aimed at improving healthcare delivery. He discusses how strategic IT investments are helping to overcome financial challenges while preparing for future opportunities.

In this Gut Doctor episode, Dr. Parikh takes on the patient role as PA Sarah Enslin discusses diagnosis and management of Barrett's esophagus. Sarah Enslin is a physician assistant at the University of Rochester Medical Center and Vice Chair of American College of Gastroenterology's Advanced Practice Provider committee. Today's episode is brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Vivek Kaul, MD The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guideline co-author Dr. Vivek Kaul. Dr. Kaul is also the Segal-Watson Professor of Medicine at the University of Rochester Medical Center in New York.

In this episode of the Pediatric and Developmental Pathology, our hosts Drs. Mike Arnold (@MArnold_PedPath) and Dr. Jason Wang speak with Dr. Philip Katzman of the University of Rochester Medical Center and Jonathan Hecht of Beth Israel-Deaconess Medical Center about their article in Pediatric and Developmental Pathology: Triaging and Evaluation of Products of Conception in Abortions and Post-Partum Hemorrhage Hear their tips for trainees about handling POC specimens, and what is different about first trimester specimens than term placentas.   Featured public domain music: Summer Pride by Loyalty Freak  

About Dr. John Martin:Dr. John Martin is a highly accomplished leader-physician with a diverse background spanning various roles, including surgeon, software company founder, medical device inventor, and Chief Medical Officer of a digital health company. He has successfully built organizations, teams, and products, transforming healthcare practices and driving innovation. Known for his ability to inspire and command audiences, Dr. Martin has extensive experience in strategic planning and fiscal management, making significant impacts both personally and through the programs and companies he develops.About Dr. Michael Rotondo:Dr. Michael F. Rotondo is a distinguished leader in healthcare, currently serving as the Chief Executive Officer of the University of Rochester Medical Faculty Group (URMFG). With a rich background in trauma surgery and healthcare administration, he has significantly contributed to transforming URMFG into a unified, high-functioning care delivery system. Under his leadership, the group has seen substantial growth in clinical volumes and revenues, while emphasizing physician wellness and health equity. Dr. Rotondo's commitment to innovative solutions and patient-centric practices continues to drive excellence in healthcare delivery.Things You'll Learn:Handheld ultrasound technology is transforming point-of-care testing, making diagnoses more immediate and accurate.Integrating handheld ultrasound technology within a health system demonstrates practical benefits, enhancing workflow and patient care.Seamless integration with electronic health records is crucial in order to improve overall efficiency and reduce treatment times.It is very important to overcome challenges in adopting new healthcare technologies like resource allocation and organizational change.Collaborations between academic institutions and tech innovators are essential for driving meaningful advancements in healthcare, promoting trust and confidence in new solutions.Resources:Connect with and follow Dr. Michael Rotondo on LinkedIn.Follow the University of Rochester Medical Center on LinkedIn and visit their website.Connect with and follow Dr. John Martin on LinkedIn.Follow Butterfly Network, Inc. on LinkedIn and visit their website.

Dr. Ruchira Singh is an Associate Professor and the recipient of the Dean's Professorship in the Department of Ophthalmology at the University of Rochester Medical Center where she also has joint appointments in the Department of Biomedical Genetics and the Center for Visual Science. Ruchira studies eye diseases to understand why some people can't see as well as others, and the knowledge gained can be used to develop new treatments for diseases like age-related macular degeneration and Batten disease, which can cause blindness. When she's not working, Ruchira loves spending time with her two kids. Even the small, everyday moments they spend together doing things like going to McDonalds, the park, or their local library bring her so much joy. Ruchira received a bachelor's degree in computer science from Jawaharlal Nehru Technological University (JNTU) in India, and she completed her graduate studies in Physiology at Kansas State University. Next, Ruchira conducted postdoctoral research in Pharmacology at Yale School of Medicine, followed by a postdoc position in stem cell research at the University of Wisconsin-Madison. She joined the faculty at the University of Rochester in 2014. In this interview, Ruchira discusses her life and science.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 2715: Sleeping without a pillow can offer some benefits, especially for stomach sleepers, but it's not a one-size-fits-all solution. While it might reduce neck strain and promote better spinal alignment for some, it can also lead to poor posture and discomfort for others, particularly those who sleep on their back or side. Whether or not to ditch the pillow largely depends on your sleep position and overall comfort. Read along with the original article(s) here: https://www.healthline.com/health/sleeping-without-a-pillow Quotes to ponder: "There are some benefits to sleeping without a pillow. However, these advantages aren't one-size-fits-all." "If you're a stomach sleeper, sleeping without a pillow may also reduce neck pain." "It's generally recommended to use a pillow if you sleep on your back or side. However, what's most important is that you feel comfortable and pain-free in bed." Episode references: University of Rochester Medical Center: https://www.urmc.rochester.edu 23andMe: Total Health membership includes services initiated and performed by third-party clinicians and lab providers through the 23andMe platform. Additional terms and conditions also apply. See 23andme.com to learn more. Total Health Membership not available to residents of HI, NJ, NY, RI and US territories. Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 2715: Sleeping without a pillow can offer some benefits, especially for stomach sleepers, but it's not a one-size-fits-all solution. While it might reduce neck strain and promote better spinal alignment for some, it can also lead to poor posture and discomfort for others, particularly those who sleep on their back or side. Whether or not to ditch the pillow largely depends on your sleep position and overall comfort. Read along with the original article(s) here: https://www.healthline.com/health/sleeping-without-a-pillow Quotes to ponder: "There are some benefits to sleeping without a pillow. However, these advantages aren't one-size-fits-all." "If you're a stomach sleeper, sleeping without a pillow may also reduce neck pain." "It's generally recommended to use a pillow if you sleep on your back or side. However, what's most important is that you feel comfortable and pain-free in bed." Episode references: University of Rochester Medical Center: https://www.urmc.rochester.edu 23andMe: Total Health membership includes services initiated and performed by third-party clinicians and lab providers through the 23andMe platform. Additional terms and conditions also apply. See 23andme.com to learn more. Total Health Membership not available to residents of HI, NJ, NY, RI and US territories. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pharmacy Vision Awards at Vizient celebrate values and achievements of our program participants. The Executive Leadership Award is granted to an individual who provides strategic insight, advances leading clinical practices, and demonstrates business acumen for their entire organization. Our 2023 winner is Dr. Curtis Haas, Chief Pharmacy Officer at the University of Rochester Medical Center. He's joins us to share his perspective on pharmacy leadership with Gretchen Brummel, your program host.   Guest speakers:  Curtis Haas, Pharm D, FCCP Director of Pharmacy University of Rochester Medical Center Host:  Gretchen Brummel, PharmD, BCPS  Verified Rx Host    Show Notes:  [00:47-05:11] Curtis Haas background and why it's important [05:12-07:02] Why elevating pharmacy practice on a state and national basis is important [07:03-08:59] Results of success by placing priority on providing resources and support and encouraging innovation [09:00-12:36] What Curtis has been doing lately at the University of Rochester Medical Center that he would like to highlight [12:37-14:53] Curtis' volunteer work outside his organization   Links | Resources:  https://verifiedrx.podbean.com/e/transcendental-medication-management-transformational-practice-in-pharmacy/   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed  

Dr. Papier is the co-founder and CEO of VisualDx. A thought leader in clinical informatics, Dr. Papier maintains the overall vision for the company with a keen focus on product integration and impacting costs in healthcare through clinical accuracy. His entrepreneurial drive, years of clinical experience, and passion for delivering true healthcare solutions have propelled the company to the forefront of clinical decision support in quality and innovation.A dermatologist and medical informatics expert, Dr. Papier has a particular interest in designing clinical decision support systems based on visually rich knowledge areas to reduce diagnostic error at the point of care. In line with this goal, he is focused on transforming medical education to include training in cognitive error and the use of information technology. Dr. Papier also focuses on consumer health by developing tools to educate and empower patients.A graduate of Wesleyan University, Dr. Papier completed his pre-med studies at Columbia University, earned his MD from the University of Vermont College of Medicine, and completed his graduate medical training at the University of Rochester Medical Center. He is an associate professor of Dermatology and Medical Informatics at the University of Rochester School of Medicine and Dentistry.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Welcome to the 158th episode of the Tooth or Dare Podcast with Irene Iancu (@toothlife.irene) and this week's guest Dr. Effrat (Effie) Habsha (@effiehabsha).  In Part 2 of this interview with Dr. Habsha, we learn about how she started Women in Dentistry, an organization dedicated to supporting female dental professionals in a traditionally male-dominated industry. They offer continuing education, mentorship, and in-person events to help members improve their clinical skills, manage work-life balance, and connect with like-minded peers. Listen to the full episode to learn more about the benefits and how to join Women in Dentistry. Effrat (Effie) Habsha, BSc, DDS, Dip. Prostho., MSc, FRCDC Dr. Effie Habsha is the Founder of Women in Dentistry: Work. Life. Balance.  She received her Bachelor of Science degree and earned her DDS degree from the University of Toronto. Upon graduation, she completed a one-year General Practice Residency at Mount Sinai Hospital in Toronto, ON. Dr. Habsha received her Diploma in Prosthodontics and Master of Science degree, both from the University of Toronto. She is a Fellow of the Royal College of Dentists of Canada (RCDC) and is an examiner and past Section Head for the Oral Examination in Prosthodontics for the RCDC. Dr. Habsha is an Adjunct Assistant Professor at the Department of Dentistry, Eastman Institute for Oral Health at the University of Rochester Medical Center. She has served as an Assistant Professor at the University of Toronto and currently instructs at the graduate level in Prosthodontics at U of T. Dr. Habsha is a Professor at George Brown College of Applied Arts and Technology and is the On-staff Prosthodontist at MedCan clinic in Toronto. She holds an appointment as Staff Prosthodontist at Mount Sinai Hospital where she instructs the dental residents and is involved in various clinical research projects. Dr. Habsha is an Associate Fellow of the Academy of Prosthodontics and Greater New York Academy of Prosthodontics, a Fellow of The Pierre Fauchard Academy and holds memberships in numerous Prosthodontic organizations and societies. She is a trailblazer and founder of Women in Dentistry: Work.Life.Balance, an organization dedicated to educating, networking and empowering women in the dental field. Dr. Habsha lectures both nationally and internationally on various Prosthodontic topics and maintains a private practice limited to Prosthodontics and Implant Dentistry in Toronto. For more information and to connect with Dr. Habsha, check out her social media profiles: Instagram: @effiehabsha, @womensdentistry Website: womenindentistry.ca If you made it all the way down here, hit a like and share a comment. Until next time, Peace out peeps! ✌️ _______________________________________  

Welcome to the 157th episode of the Tooth or Dare Podcast with Irene Iancu (@toothlife.irene) and this week's guest Dr. Effrat (Effie) Habsha (@effiehabsha).  Do you love your smile? Dr. Habsha's goal is to make sure her patients do. As a prosthodontist, every day can be a new challenge. Figuring out how to bring out the best smile in everyone can be difficult but very rewarding - and sometimes, a few small modifications can go a long way. Listen to the full episode to learn how Dr. Habsha fell in love with her specialty, how digital technology has improved the smile design process, and whether or not implants need the same attention as real teeth… The answer may surprise you! Effrat (Effie) Habsha, BSc, DDS, Dip. Prostho., MSc, FRCDC Dr. Effie Habsha is the Founder of Women in Dentistry: Work. Life. Balance.  She received her Bachelor of Science degree and earned her DDS degree from the University of Toronto. Upon graduation, she completed a one-year General Practice Residency at Mount Sinai Hospital in Toronto, ON. Dr. Habsha received her Diploma in Prosthodontics and Master of Science degree, both from the University of Toronto. She is a Fellow of the Royal College of Dentists of Canada (RCDC) and is an examiner and past Section Head for the Oral Examination in Prosthodontics for the RCDC. Dr. Habsha is an Adjunct Assistant Professor at the Department of Dentistry, Eastman Institute for Oral Health at the University of Rochester Medical Center. She has served as an Assistant Professor at the University of Toronto and currently instructs at the graduate level in Prosthodontics at U of T. Dr. Habsha is a Professor at George Brown College of Applied Arts and Technology and is the On-staff Prosthodontist at MedCan clinic in Toronto. She holds an appointment as Staff Prosthodontist at Mount Sinai Hospital where she instructs the dental residents and is involved in various clinical research projects. Dr. Habsha is an Associate Fellow of the Academy of Prosthodontics and Greater New York Academy of Prosthodontics, a Fellow of The Pierre Fauchard Academy and holds memberships in numerous Prosthodontic organizations and societies. She is a trailblazer and founder of Women in Dentistry: Work.Life.Balance, an organization dedicated to educating, networking and empowering women in the dental field. Dr. Habsha lectures both nationally and internationally on various Prosthodontic topics and maintains a private practice limited to Prosthodontics and Implant Dentistry in Toronto. For more information and to connect with Dr. Habsha, check out her social media profiles: Instagram: @effiehabsha, @womensdentistry Website: womenindentistry.ca If you made it all the way down here, hit a like and share a comment. Until next time, Peace out peeps! ✌️ _______________________________________  

In today's episode of Beating Cancer Daily, Saranne dives into the empowering topic of controlling what we can in the midst of a cancer journey. Having triumphed over Stage IV cancer, Saranne knows firsthand the chaos that such a diagnosis can introduce. She discusses actionable strategies to focus on manageable aspects of life, drawing inspiration from a poster she found on Etsy and research from the University of Rochester Medical Center. Listen in as Saranne outlines micro habits that foster a sense of control and well-being, offering hope and resilience even in the most difficult times. Let's explore these practical steps together, living our best days and beating cancer daily.The #1 Rated Cancer Survivor Podcast by FeedSpot and Ranked Top 5 Best Cancer Podcast by CancerCare News. Beating Cancer Daily is listened to in over 80 countries on 6 continents and has over 270 daily episodes!  In 1999, Saranne launched The ComedyCures Foundation from her chemo chair with a "Chemo Comedy Party." Now cancer-free, she's dedicated her life to helping others find strength, courage, and laughter in their fight against cancer. As a healthcare thought leader, speaker, patient advocate, and health and happiness expert, Saranne's work has garnered recognition and support from prestigious organizations like the NIH/NCI, the United Nations, the World Health Organization, and numerous universities and cancer societies. Saranne's transformative strategies, research findings, fun, practical tips, and comic insights can be found in the "Beating Cancer Daily" podcast and the BCD Membership Circle, where she helps listeners navigate their treatment and survivorship with humor and resilience. Are you wondering How You Can Support Beating Cancer Daily and ComedyCures.org?By becoming a supporter of ComedyCures.org, you'll help us continue our essential programs and research. Your generosity will significantly impact cancer patients, caregivers, doctors, nurses, and researchers worldwide. Choose your level of support:• Supporter: $50 (or $5 per month)• Friend: $150 (or $15 per month)• Champion: $500 (or $50 per month)• VIP: $5,000 annually Donate Herehttps://www.paypal.com/donate?hosted_button_id=GDPQCM8PHJT We Share the Laughter with Beating Cancer Daily Podcast Do you love the podcast? Please share it with a friend and spread the laughter!  

In this episode, my guest speaker, Dr Ray Dorsey, a Professor Of Neurology and Director of the Center for Human Experimental Therapeutics at the University of Rochester Medical Center, will share the shocking root cause of Parkinson's and Alzheimer's Disease. Dr. Dorsey explains how environmental toxins in our food, water, and air are at the root cause of brain diseases like Parkinson's and Alzheimer's. He and his team of 14 neurologists have published evidence proving that a chemical found in drinking water, and food and common cleaning products is causing the alarming rise of Parkinson's disease, and specifically, air pollution is highly linked to Alzheimer's Disease. In this episode, Dr Dorsey details the 3 common toxic chemicals in our environment and simple protocols to implement relating to the food we eat, what we drink, and the air we breathe. This episode is important for every person who wants to prevent brain diseases like Parkinson's and Alzheimer's, and particularly for people who have an existing diagnosed brain disease.

In this episode, we are joined by Dr. Heather Florescue to discuss the vital but often overlooked topic of stillbirth prevention. Dr. Florescue introduces the concept of placental health, the importance of measuring estimated placental volume, and the role this plays in ensuring healthy pregnancies. We dive deep into the current research, debunk myths, and highlight the significance of understanding risk factors and maternal instincts. Dr. Florescue also shares insights on protocols followed in the UK and Australia that could help reduce stillbirth rates. Tune in to learn why education and proactive healthcare can save lives.   Guest Bio: Dr. Florescue is an ob.gyn. in private practice at Women Gynecology and Childbirth Associates in Rochester, N.Y. She delivers babies at Highland Hospital in Rochester, NY.  She received her medical degree at the University of Rochester School of Medicine & Dentistry, completed her internship and residency in obstetrics & gynecology at the University of Rochester Medical Center.  She is certified by the American Congress of Obstetrics & Gynecology.  She and her husband are parents to a set of triplets.  Dr. Florescue is passionate about the prevention of pregnancy and infant loss and the care for families who suffer these terrible tragedies.    INSTAGRAM: Connect with HeHe on IG  Connect with Dr. Florescue on IG    BIRTH EDUCATION: Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience! Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone!   LINKS MENTIONED: Star Legacy Foundation Count the Kicks PUSH Pregnancy Tommys.org Saving Babies Lives Care Bundles

In this episode, recorded at the 21st Annual Spine Orthopedic and Pain Management-Driven ASC + the Future of Spine Conference, Dr. Catherine Humphrey, Professor of Orthopaedic Surgery at University of Rochester Medical Center discusses the evolving patient-provider dynamic and its impact on healthcare delivery.Disclosure: This content is subject to change without notice and offered for informational use only. You are urged to consult with your individual business, financial, legal, tax and/or other advisors [and/or medical providers] with respect to any information presented. Synchrony and any of its affiliates, including CareCredit, (collectively, “Synchrony”) makes no representations or warranties regarding this content and accept no liability for any loss or harm arising from the use of the information provided. All statements and opinions in [describe the document/presentation/ recording/podcast] are the sole opinions of the [speaker/author/guest]. Your receipt of this material constitutes your acceptance of these terms and conditions.

In this episode, recorded at the 21st Annual Spine Orthopedic and Pain Management-Driven ASC + the Future of Spine Conference, Dr. Catherine Humphrey, Professor of Orthopaedic Surgery at University of Rochester Medical Center discusses the evolving patient-provider dynamic and its impact on healthcare delivery.Disclosure: This content is subject to change without notice and offered for informational use only. You are urged to consult with your individual business, financial, legal, tax and/or other advisors [and/or medical providers] with respect to any information presented. Synchrony and any of its affiliates, including CareCredit, (collectively, “Synchrony”) makes no representations or warranties regarding this content and accept no liability for any loss or harm arising from the use of the information provided. All statements and opinions in [describe the document/presentation/ recording/podcast] are the sole opinions of the [speaker/author/guest]. Your receipt of this material constitutes your acceptance of these terms and conditions.

Men have many challenges to deal with when battling prostate cancer, including managing the side effects of their treatment.  One common issue men face after a radical prostatectomy is erectile dysfunction. As June is Men's Health Month, we are fortunate to have men's health expert Dr. Helen Bernie joining us today to provide a modern perspective on restoring erectile function post-prostatectomy through penile rehabilitation. Dr. Bernie is a board-certified and fellowship-trained urologist. She is the Director of Sexual and Reproductive Medicine, the Andrology Fellowship Program Director, and the Assistant Professor of Urology at the Indiana University School of Medicine, where she teaches medical students. She is passionate about men's health, cancer survivorship, and fertility preservation, and she treats all aspects of men's health, including male sexual dysfunctions and infertility. Dr. Bernie completed her residency in urology at the University of Rochester Medical Center and did a two-year fellowship in sexual and reproductive medicine at Memorial Sloan Kettering Cancer Centre and New York Presbyterian Weill Cornell Medical College. She has presented award-winning research on sexual medicine, testosterone replacement, prostate cancer, and male fertility. Stay tuned as Dr. Bernie shares her expert insights and practical advice on how men can reclaim their sexual health after prostate cancer treatment. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.   Show Highlights: How prostate removal or prostate cancer may affect men's sexual function How often does erectile dysfunction occur after a radical prostatectomy? Dr. Bernie shares some of the many options available for men to regain erectile function after a prostatectomy. Some of the barriers that exist in instituting penile rehabilitation Dr. Bernie shares her current approach to penile rehabilitation.  Why it is crucial for anyone diagnosed with prostate cancer or experiencing erectile dysfunction to find out what a penile rehabilitation program is and what it involves. Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Indiana University School of Medicine   Indiana University Andrology Fellowship Program Indiana University Urology Services

The Body Mass Index (BMI) is a long-standing measure used in healthcare. But this height/weight ratio was originally meant for statistical use only and has no proven standing as a measure of health. Yet a patient's BMI is used to make critical decisions about their care. In this episode, Dr. Holly Ann Russell, an associate professor of family medicine at the University of Rochester Medical Center and medical director for the Center of Community Health and Prevention, discusses what measures providers should be focusing on instead and why weighing patients at every visit is unnecessary.

Dr. Art Papier believes we are focusing on the wrong questions in medicine, and for the best care of patients, we need augmented intelligence. Dr. Art Papier, MD is Chief Executive Officer and co-founder of VisualDx. He is a dermatologist, medical informatics expert, and Associate Professor of Dermatology and Medical Informatics at the University of Rochester School of Medicine and Dentistry. Dr. Papier graduated from Wesleyan University, the University of Vermont College of Medicine, and completed graduate medical training at the University of Rochester Medical Center. His interests span healthcare costs as related to clinical accuracy, clinical decision support systems, diagnostic error reduction, cognitive error, medical education, and empowering patients. 

FUTURE OF MARKETING SERIES: Kyle Smith, Noom Kyle Smith, Head of Marketing for Healthcare at Noom, joins Jared and guest co-host Paul Schrimpf for the first in a special mini-series about the future of marketing. Hear how Noom's consumer business was born from failure and how Kyle's team experiments with new tools, looks for value, and either adopts them or moves on.  All that, plus the Flava of the Week about University of Rochester Medical Center's innovative way to bring healthcare to bank branches. How is URMC using unconventional partnerships to improve access in rural communities, and what other solutions can we discover as we follow their lead with more collective problem solving?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, we are joined by Lainie Ross (University of Rochester Medical Center) and (once again!) Christos Lazaridis (UChicago Medicine), this time to talk about the different ways of defining death.In our previous episode with Christos, we talked about death and the vexed history of attempts to define it. Prior to the advent of modern life support technology in the 1950s, it was usually enough to check whether a person had a heartbeat and could breathe to determine whether they were dead. But once machines were invented that could breathe and circulate blood in patients whose lungs or hearts were failing, a new moral conundrum was born: how do you decide whether a medical patient is dead when it is now possible to keep their lungs breathing and their heart beating indefinitely?In this episode, our distinguished guests talk about the actual criteria that physicians use to determine whether a patient is dead, as well as some possible criteria that no one has tried applying but which some doctors think would be more appropriate. Furthermore, Lainie Ross argues that every person has the right to choose which criteria will be used to determine whether they are dead. These two topics interact in interesting ways.For example, I might have a strong preference for my doctor to pronounce me dead only if I have permanently lost all consciousness, even if I can still spontaneously breathe. Although we currently have no good method of objectively measuring whether a patient has permanently lost consciousness, Dr. Ross argues that I have the moral right to sign an agreement stating my preferences. Specifically: the agreement could state that if, in the future, the technology for determining whether someone has permanently lost consciousness gets invented, and, at that time, I have permanently lost consciousness, then I should be declared dead. On the flipside, some patients prefer a stricter criterion, often for religious reasons. Perhaps it is my religious belief that if I am breathing, then I should be considered to be alive. Lainie Ross argues that in that case, I have the moral right to sign an agreement stating that that is the criterion that doctors will use on me, in the event that I lose consciousness but am still able to spontaneously breathe.As of right now, people only have the legal right to sign these types of agrreements in a handful of states in the US. Join us for this episode as Christos Lazaridis and Lainie Ross argue for making this legal right more widespread! Hosted on Acast. See acast.com/privacy for more information.

BJJ Meditations sits at the intersection of Jiu Jitsu and the examined life. Part of living an examined life is tending to health and well-being. Skin health presents one of the most complex and pressing challenges in the life of a grappler. What are the best practices and protocols we can use to protect ourselves and our training partner? Dr. Clayton Green is a board-certified dermatologist and associate professor of clinical dermatology at the University of Rochester Medical Center. He's also a BJJ blue belt. In this episode, Doc Green and I go deep on: -- Common diseases of the skin -- Skin care best practices and products -- Gear care best practices and products -- Methods for maintaining a clean training environment Doc Green has graciously offered his personal e-mail address, should you have any questions about skin health in Jiu Jitsu. Just keep in mind that he may not be licensed to practice in your state and consequently, he may provide more general health insights instead of specific skin care advice. You can contact him at green.clayton@gmail.com. Some weird thoughts and reflections on all of these things in this week's BJJ Meditations. Work with me: https://www.bjjmeditations.com/schedule-a-coaching-session Train at Princeton Brazilian Jiu Jitsu: https://www.princetonbjj.com/ Read more of my work on Substack: https://joehannan.substack.com/ Follow BJJ Meditations on Instagram: https://www.instagram.com/bjj_meditations/ #bjj #jiujitsu #stoic #stoicism

Hosts Alan Sardana & Dr. Joshua Liu speak with Dr. Michael Hasselberg, Chief Digital Health Officer at University of Rochester Medical Center, about the "Frontiers in Telepsychiatry, Open-Source Innovation, Why Healthcare Startups Should Focus on Higher Level Problems, and more." Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Kyle Smith, Head of Marketing for Healthcare at Noom, joins Jared and guest co-host Paul Schrimpf for the first in a special mini-series about the future of marketing. Hear how Noom's consumer business was born from failure and how Kyle's team experiments with new tools, looks for value, and either adopts them or moves on.  All that, plus the Flava of the Week about University of Rochester Medical Center's innovative way to bring healthcare to bank branches. How is URMC using unconventional partnerships to improve access in rural communities, and what other solutions can we discover as we follow their lead with more collective problem solving?  This show is produced by Shift Forward Health, the consumer advisory firm that partners with you to operationalize consumer-first health. (#310) See omnystudio.com/listener for privacy information.

How much of an impact can Generative AI have – if leveraged properly, and if all the necessary pieces are in place? Quite a bit, according to Michael Hasselberg. “This is the first time in my career thus far that I'm hopeful that technology will actually make the lives of our clinicians better.” In a recent interview, he explained why, and talked about the innovative work being done at URMC. Source: “This Is Real Innovation”: Q&A with Michael Hasselberg, CDHO, University of Rochester Medical Center on healthsystemcio.com - healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.

In Episode 61 of Bladder Cancer Matters, Dr. Brendan Guercio, a medical oncologist and assistant professor at the University of Rochester Medical Center, discusses the use of immunotherapy in the treatment of bladder cancer.  He explains that immunotherapy works by training the immune system to identify and fight cancer cells, unlike chemotherapy which directly kills cancer cells. Dr. Guercio focuses on immune checkpoint inhibitors, a type of immunotherapy that blocks proteins used by cancer cells to turn off the immune system. He discusses the effectiveness of checkpoint inhibitors, with about 25-30% of patients experiencing significant tumor shrinkage. Dr. Guercio also explores the potential impact of diet on immunotherapy response, specifically looking at probiotics, prebiotics, fiber, and antibiotics. While there is promising evidence that certain probiotics and higher fiber intake may be beneficial, larger studies are needed to confirm these findings. He emphasizes the importance of discussing these topics with a healthcare provider and highlights the role of organizations like the Bladder Cancer Advocacy Network (BCAN) in supporting research in this area.

In this episode of the Impostor Syndrome Files, we talk about what happens when we put everyone else's needs above our own. If you're living your life or managing your career on someone else's terms, eventually it's going to catch up with you. My guest this week, Jen Schwytzer, is a life coach who shares her journey from social work in a hospital setting to coaching others to manage stress and overwhelm. Jen shares how putting herself last led to burnout and loss of love for the work she did and how changing her career empowered her to prioritize herself and her family. We also explore steps you can take to start putting yourself first, even if it feels scary and uncomfortable to do so.  About My GuestJen Schwytzer is a certified Life Coach and launched KINDfulness Coaching to help professionals ditch chronic stress and overwhelm and establish calm, productive order in life and business. Jen has 17 years of experience as a social worker in both the medical and mental health arena which allows her to bring a unique experience to her coaching practice. Jen has won the Award for Excellence in Outstanding Social Work from the University of Rochester Medical Center and continues to provide mental health education through partnerships with American Foundation for Suicide Prevention.~Connect with Jen:Website: www.kindfulnesscoaching.com Instagram: www.instagram.com/kindfulness_coaching~Connect with Kim and The Impostor Syndrome Files:Join the free Impostor Syndrome Challenge:https://www.kimmeninger.com/Learn more about the Leading Humans discussion group:https://www.kimmeninger.com/coachingJoin the Slack channel to learn from, connect with and support other professionals: https://forms.gle/Ts4Vg4Nx4HDnTVUC6Join the Facebook group:https://www.facebook.com/groups/leadinghumansSchedule time to speak with Kim Meninger directly about your questions/challenges: https://bookme.name/ExecCareer/strategy-sessionConnect on LinkedIn:https://www.linkedin.com/in/kimmeninger/Website:https://kimmeninger.com

In 2021, federal rules from the 21st Century Cures Act mandated that most clinical notes be made available in real-time, online and free of charge to patients. This practice, commonly known as “open notes,” was a significant step towards enhancing medical information transparency–– a vital step in reinforcing trust in the provider-patient relationship. However, it also introduced complexities, raising questions as to what to include in the notes. “The ethical analysis does not always align with the legal analysis, and these are conversations that ethicists are aware of,” Steven Bondi, MD, JD, says. Dr. Bondi, a lawyer turned doctor, is renowned for his expertise on the Cures Act, Open Notes and Electronic Medical Records. He specializes in pediatric medicine at Golisano Children's Hospital and is an associate professor within the Department of Pediatrics at the University of Rochester Medical Center. “I think that knowledge is important, and we need to know what the law says and what its parameters are and when we can use the exceptions,” Dr. Bondi says. Dr. Bondi recommends multiple resources on this topic. He suggests visiting healthit.gov and navigating to their information blocking section for informative FAQs and webinars. He also recommends the Guttmacher Institute as a source for general knowledge around adolescent health and privacy. Lastly, he explains that he was recently a part of the American Academy of Pediatrics' committee on medical liability and risk management where he helped produce a monthly column called ‘Pediatricians in Law.' This episode was recorded at the 2023 American Academy of Pediatrics National Conference and Exhibition. Some highlights from this episode include:  How to navigate difficult situations and avoid labels  The role that ethics play in this discussion Confidentially in adolescents by state Biggest pitfalls and gray areas  For more information on Children's Colorado, visit: childrenscolorado.org    

Dr. Mark Oldham, Associate Professor of Psychiatry at University of Rochester Medical Center, President-Elect of the American Delirium Society, and Deputy Editor of the Journal of the Academy of Consultation-Liaison Psychiatry, takes us through a deep dive on delirium. This episode covers an enormous amount of material. Contrast  encephalopathy and delirium before diving into the dangerousness of delirium and prevention strategies. Explore the neurobiology of delirium and tie it to validated assessment tools and treatment approaches. We also discuss areas for future research, and learn to appreciate the evolutionary function that delirium serves.This episode also deserves some references! (3:38) Lipowski ZJ. Delirium: Acute Brain Failure in Man. Springfield, IL: Charles C Thomas, 1980.  (7:55) Slooter AJC, Otte WM, Devlin JW, et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med. 2020;46(5):1020-1022.  (21:46)  Marcantonio ER, Ngo LH, O'Connor M, et al. 3D-CAM: derivation and validation of a 3-minute diagnostic interview for CAM-defined delirium: a cross-sectional diagnostic test study [published correction appears in Ann Intern Med. 2014 Nov 18;161(10):764]. Ann Intern Med. 2014;161(8):554-561.   (29:50) Kunicki ZJ, Ngo LH, Marcantonio ER, et al. Six-Year Cognitive Trajectory in Older Adults Following Major Surgery and Delirium. JAMA Intern Med. 2023;183(5):442-450.   (41:40) Mews MR, Tauch D, Erdur H, Quante A. Comparing consultation-liaison psychiatrist's and neurologist's approaches to delirium - A retrospective analysis. Int J Psychiatry Med. 2016;51(3):284-301. = (1:08:08) Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018;379(26):2506-2516.   (1:09:33) Hui D, Frisbee-Hume S, Wilson A, et al. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017;318(11):1047-1056.   (1:31:36) By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081.  (1:33:54) Burton JK, Craig LE, Yong SQ, et al. Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2021;7(7):CD013307. Published 2021 Jul 19.   (1:35:41) Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial. Am J Respir Crit Care Med. 2018;197(9):1147-1156.   (1:36:00) Subramaniam B, Shankar P, Shaefi S, et al. Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: The DEXACET Randomized Clinical Trial [published correction appears in JAMA. 2019 Jul 16;322(3):276]. JAMA. 2019;321(7):686-696. 

Dr. Mark Oldham, Associate Professor of Psychiatry at University of Rochester Medical Center, President-Elect of the American Delirium Society, and Deputy Editor of the Journal of the Academy of Consultation-Liaison Psychiatry, takes us through a deep dive on delirium. This episode covers an enormous amount of material. We contrast encephalopathy and delirium before diving into the dangerousness of delirium and prevention strategies. We explore the neurobiology of delirium and tie it to validated assessment tools and treatment approaches. We also discuss areas for future research and learn to appreciate the evolutionary function that delirium serves. References can be found on the episode website.

This episode recorded live at the 8th Annual Becker's HIT + DH + RCM Conference in Chicago features Michael Hasselberg, Chief Digital Health Officer, University of Rochester Medical Center. Here, he discusses his excitement surrounding generative AI, top priorities he is focusing on in his role, the future of healthcare, and more!In collaboration with Philips.

This episode is brought to you by Rupa Health, Mitopure, and Cozy Earth. Histamine is a common term when discussing allergies, but there is really so much more to it. Histamine is both made by the body and found in food. It has a key function in digestion and also acts as a neurotransmitter. People who have more histamine in their bodies than they can break down may experience a variety of symptoms including hives, heart palpitations, migraines, fluid retention, runny nose, and more. Often, histamine intolerance can be traced back to gut dysbiosis and mast cell activation syndrome.In today's episode, I talk with Dr. Todd LePine, Dr. Leo Galland, and Lisa Dreher about how histamine plays a role in sleep, digestion, allergies, skin conditions, and so much more.Dr. Todd LePine graduated from Dartmouth Medical School and is board certified in internal medicine, specializing in integrative Functional Medicine. He is an Institute for Functional Medicine Certified Practitioner. Prior to joining The UltraWellness Center, he worked as a physician at Canyon Ranch in Lenox, MA, for 10 years.Dr. Leo Galland is a board-certified internist, an international bestselling author, and one of the founders of Functional Medicine. Since the onset of the pandemic, he has devoted most of his time to research on Covid-19 and to the education of other health practitioners in understanding the biology of the disease. His latest publication, Long Covid: Prevention and Treatment, is available on his website.Lisa Dreher is a registered dietitian who got her undergraduate nutrition degree at the Rochester Institute of Technology and completed a dietetic internship through Cornell University. Lisa first worked in the acute care hospital setting and became a clinical nutrition specialist working in pediatric gastroenterology at the University of Rochester Medical Center. At the same time, she pursued her master's degree in nutrition and integrative health from the Maryland University of Integrative Health and started practicing integrative and functional nutrition in private practice before joining The UltraWellness Center in 2015.This episode is brought to you by Rupa Health, Mitopure, and Cozy Earth.Access more than 3,000 specialty lab tests with Rupa Health. You can check out a free, live demo with a Q&A or create an account at RupaHealth.com today.Support the growth of new, healthy mitochondria and get 10% off Mitopure. Head to timelinenutrition.com/drhyman and use code DRHYMAN10 at checkout.Get 40% off your Cozy Earth sheets. Just head over to cozyearth.com and use code DRHYMAN.Full-length episodes of these interviews can be found here:Dr. Todd LePine (histamine intolerance)Dr. Leo GallandDr. Todd LePine (ending migraines)Lisa Dreher Hosted on Acast. See acast.com/privacy for more information.

Today you'll learn about new research that shows a link between a widely used chemical and Parkinson's Disease, why where we live no longer determines who we love, and another reason cats rule. Parkinson's Chemical “Common dry cleaning chemical linked to Parkinson's.” by University of Rochester Medical Center. 2023. https://medicalxpress.com/news/2023-03-common-dry-chemical-linked-parkinson.html“Meet Amy Lindberg - ParkinsonTV Live: The Long Road To Hope.” YouTube Video. 2022. https://www.pmdalliance.org/portfolio/meet-amy-lindberg-parkinsontv-live-the-long-road-to-hope/“Trichloroethylene (TCE) and Your Health.” n.a. 2023. https://www.health.state.mn.us/communities/environment/hazardous/topics/tce.htmlFar Away Love  “Why People Look Farther Away for Love.” by Theresa E. DiDonato Ph.D. 2023. https://www.psychologytoday.com/us/blog/meet-catch-and-keep/202303/why-people-look-farther-away-for-loveSecrets of Catnip  “When Cats Chew Catnip, It Works as a Bug Spray.” by Sam Zlotnik. 2022. https://www.smithsonianmag.com/science-nature/when-cats-chew-catnip-they-make-it-a-better-bug-spray-180980261/“Silver Vine for Cats: Benefits and Safety Information.” by Katie Woodley, DVM. 2022. https://www.greatpetcare.com/wellness/silver-vine-for-cats/Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.